Evidence map›Paper›PMID 40596746›Full record

ArticleJournal of cellular and molecular medicine2025

Global Thyroid Cancer Patterns and Predictive Analytics: Integrating Machine Learning for Advanced Diagnostic Modelling.

Yao Sun, Yongsheng Jia, Kuan Fu, Xiaoyong Yang, Peiguo Wang, Zhiyong Yuan

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yao SunDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Yongsheng JiaDepartment of Thyroid and Neck Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Kuan FuDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Xiaoyong YangDepartment of Thyroid and Neck Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Peiguo WangDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.
Zhiyong YuanDepartment of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China.ORCID 0000-0002-3134-7790

Funding

the National Natural Science Foundation of China No. 82303686the Tianjin Education Commission General-level Natural Science Project No. 2022KJ224the Tianjin Key Medical Discipline (Specialty) Construction Project No. TJYXZDXK-009A
6 · The paper itself

Abstract

backgroundThe global increase in thyroid cancer prevalence, particularly among female populations, underscores critical gaps in our understanding of molecular pathogenesis and diagnostic capabilities. Our investigation addresses these knowledge deficits by examining molecular signatures and validating diagnostic markers using clinical specimens to facilitate earlier detection and targeted therapeutic development.

methodsWe conducted comprehensive analyses of thyroid cancer specimens through multiple methodologies. Quantitative PCR and ELISA techniques were employed to quantify gene expression profiles and cytokine concentrations. High-resolution single-cell transcriptomics illuminated cellular communications within the tumour ecosystem, with particular emphasis on myeloid cell interactions mediated by MIF and GALECTIN signalling networks. Rigorous statistical frameworks were implemented to evaluate differential expression patterns and cytokine alterations.

resultsOur analyses demonstrated pronounced elevation of both pro-inflammatory mediators (TNF-α, IL-6, IL-8, VEGF) and immunoregulatory cytokines (TGF-β, IL-10) in neoplastic tissues relative to non-malignant adjacent regions, with magnitude changes of 2.5-4.0 fold (p < 0.05). Network analysis revealed distinctive gene modules, notably MEblue and MEmagenta, exhibiting strong positive correlations with disease progression. Computational diagnostic algorithms, particularly penalised regression models (Ridge, Lasso), exhibited exceptional discriminatory capacity, achieving 0.963 AUC in external validation (GSE27155 dataset). Single-cell profiling uncovered extensive communication networks centred on myeloid cell populations, with MIF and GALECTIN pathways emerging as critical mediators of tumour development and immune suppression.

conclusionOur findings expand the molecular understanding of thyroid carcinogenesis, highlighting the significance of myeloid-centered communication networks. The molecular signatures and gene modules identified represent promising candidates for diagnostic applications and personalised therapeutic targeting. Prospective validation in expanded and heterogeneous patient populations remains essential to confirm clinical utility and optimise implementation strategies.

Indexed as

Machine LearningThyroid NeoplasmsBiomarkers, TumorCytokinesFemaleGalectinsGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMaleTranscriptomeBiomarkers, TumorCytokinesGalectinsIntramolecular OxidoreductasesMacrophage Migration-Inhibitory FactorsMIF protein, humancancer immunologymachine learning modelMIF signalling pathwaymyeloid cellsthyroid cancer

Identifiers

PMID40596746
PMCPMC12213443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.